Advertisement

Topics

Drug Development Technology Company Profile

11:01 EST 21st November 2017 | BioPortfolio

Established in 1972, SPG Media PLC is an international business-to-business media company providing world-class controlled circulation magazines, internet reference portals, business conferences and forums.
Our extensive expertise, built through a long history in publishing, has led to an impressive array of products. Our well-respected websites have established themselves as leading sources of information within the industries they serve while our print publications feature editorial content designed to present and analyse cutting edge technology and strategies.
Our mission is to provide senior executives, decision-makers and business communities throughout the world with valued information and services, by communicating industry developments, offering informed opinion and promoting our customers' products and servises

Location

Brunel House55-57 North Wharf Road
London
London
W2 1LA
United Kingdom

Contact

Phone: 44 207 915 9957
Fax: 44 207 915 9958
Email: sundeepmakkar@spgmedia.com


News Articles [2157 Associated News Articles listed on BioPortfolio]

UK and Canada Link in Antibacterial Drug Project

LifeArc, the UK medical research charity previously known as MRC Technology, is to collaborate with the government’s Defence Science and Technology Laboratory (Dstl) and Canada’s Centre fo...

Cancer Research Technology: Driving Cancer Drug Development

In this programme Fintan Walton talks to Dr Keith Blundy, CEO of Cancer Research Technology, the drug development and commercialisation arm of Cancer Research UK. Having described the relationship bet...

DARTS Technology Launches New Drug Target Identification Service Designed To Streamline Drug Development

  Life Sciences Jobs   ...

DARTS Technology Launches New Drug Target Identification Service Designed to Streamline Drug Development

Enables Identification of Potential Side Effects Before Trials DARTS Sciences, Inc. (www.dartssciences.com) has obtained an exclusive license for the DARTS patent (Drug Affini...

Science Says: Gene Editing Widely Used in Range of Research

NewsGene editing is getting fresh attention thanks to a successful lab experiment with human embryos. Despite angst over possibly altering reproduction years from now, the technology already is used b...

China Joins Pursuit of Global Drug Development Standards

BlogDrug development is a global endeavor, requiring international collaboration to ensure that consistent standards are adopted and adhered to by all drug makers and regulatory authorities, regardles...

Drug Development at the Portfolio Level

This Viewpoint discusses the drug development portfolio—a family of trials assessing a drug for different indications or in different combinations with other drugs—and summarizes some of the chall...

F.I.R.S.T.™ - a platform for effective drug discovery

The strategic value of BioInvent consists of the patented technology platforms F I R S T™ and n-CoDeR®, as well as considerable expertise in pre-clinical and clinical development and the production...

PubMed Articles [4701 Associated PubMed Articles listed on BioPortfolio]

Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014.

Understanding the drug development pathway is critical for streamlining the development of effective cancer treatments. The objective of the current study was to delineate the drug development timelin...

Microfluidics technology for drug delivery: A review.

Microfluidics is undoubtedly an influential technology that is currently revolutionizing the chemical and biological studies by replicating laboratory bench-top technology on a miniature chip-scale de...

The potential of multi-compound nanoparticles to bypass drug resistance in cancer.

The therapeutic efficacy of conventional chemotherapy against several solid tumors is generally limited and this is often due to the development of resistance or poor delivery of the drugs to the tumo...

The ProTide Prodrug Technology: From the Concept to the Clinic.

The ProTide technology is a prodrug approach developed for the efficient intracellular delivery of nucleoside analogue monophosphates and monophosphonates. In this approach, the hydroxyls of the monop...

Life Under the Microscope: Quantifying Live Cell Interactions to Improve Nanoscale Drug Delivery.

The behavior of cells and how they react to stimuli is critically important for drug development, drug delivery, and understanding the molecular basis of many diseases. However, we still lack a compre...

Clinical Trials [4556 Associated Clinical Trials listed on BioPortfolio]

Improving Outcomes Using Technology for Children Who Are DHH

This study evaluates the efficacy of using augmentative and alternative communication (AAC) technology for enhancing language development in children who are deaf or hard of hearing. Half ...

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Drug-resistant tuberculosis is becoming a major problem for the whole humanity, and development of new Anti-TB drugs is of great importance. Since Kazakhstan is a country with the high bur...

Imaging the Neurochemistry of Drug Addiction With PET

Our project has two overarching goals. 1) We will use newly developed positron emission tomography (PET) technology to investigate the dopaminergic neurochemistry of drugs of abuse includi...

Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis

Background: Drug resistant tuberculosis is a serious public health problem that threatens the health of human life and the development of society and economy. At present, the diagnosis of...

Development of a Screening Strategy for Community-Based Adverse Drug Related Events in the Emergency Department

Adverse Drug Related Events (ADREs) are a leading cause of Emergency Department (ED) visits in Canada. However emergency physicians recognize only half of all ADREs in patients presenting ...

Companies [4334 Associated Companies listed on BioPortfolio]

Receptron Incorporated

Receptron has a novel and proprietary position in drug discovery and development. The company's original focus was on diabetes but now has expanded to include a diverse portfolio of research and devel...

Locum International

The Locum International Group is a limited Research Association comprising of :(a.) A Pharmaceutical Research and Development Company with extensive experience in product development, manufacturing, r...

TransPharma Medical Ltd

stablished in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug del...

Anchor Therapeutics, Inc.

Anchor Therapeutics, Inc. is a leader in the development of pepducin technology. The Company is engaged in the licensing of pepducin technology as research tools for drug developm...

Penwest Pharmaceuticals

Penwest Pharmaceuticals is engaged in the research, development and commercialization of novel drug delivery technologies. Based on its extensive expertise in developing and manufacturing tabletting i...

More Information about "Drug Development Technology" on BioPortfolio

We have published hundreds of Drug Development Technology news stories on BioPortfolio along with dozens of Drug Development Technology Clinical Trials and PubMed Articles about Drug Development Technology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Drug Development Technology Companies in our database. You can also find out about relevant Drug Development Technology Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record